Abstract:The aim of this research is to study the phenotype, genotype, treatment strategies, and short-term prognosis of Chinese children with ATP1A3 (Na+/K+-ATPase alpha 3 gene)-related disorders in Southwest China. Patients with pathogenic ATP1A3 variants identified using next-generation sequencing were registered at the Children's Hospital of Chongqing Medical University from December 2015 to May 2019. We followed them as a cohort and analyzed their clinical data. Eleven patients were identified with de novo pathogenic ATP1A3 heterozygous variants. One (c.2542 + 1G > T, splicing) has not been reported. Eight patients with alternating hemiplegia of childhood (AHC), one with cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS), and two with relapsing encephalopathy with cerebellar ataxia (RECA) were included. The initial manifestations of AHC included hemiplegia, oculomotor abnormalities, and seizures, and the most common trigger was an upper respiratory tract infection without fever. All patients had paroxysmal hemiplegic attacks during their disease course. The brain MRI showed no abnormalities. Six out of eight AHC cases reached a stable disease state after treatment. The initial symptom of the patient with CAPOS was ataxia followed by developmental regression, seizures, deafness, visual impairment, and dysarthria, and the brain MRI indicated mild cerebellar atrophy. No fluctuation was noted after using Acetazolamide. The initial manifestations of the two RECA cases were dystonia and encephalopathy, respectively. One manifested a rapid-onset course of dystonia triggered by a fever followed by dysarthria and action tremors, and independent walking was impossible. The brain MRI image was normal. The other one presented with disturbance of consciousness, seizures, sleep disturbance, tremor, and dyskinesias. The EEG revealed a slow background (δ activity), and the brain MRI result was normal. No response to Flunarizine was noted for them, and it took 61 and 60 months for them to reach a stable disease state, respectively. Conclusion: Pathogenic ATP1A3 variants play an essential role in the pathogenesis of Sodium-Potassium pump disorders, and AHC is the most common phenotype. The treatment strategies and prognosis depend on the phenotype categories caused by different variation sites and types. The correlation between the genotype and phenotype requires further exploration. What is known: • Pathogenic heterozygous ATP1A3 variants cause a spectrum of neurological phenotypes, and ATP1A3-disorders are viewed as a phenotypic continuum presenting with atypical and overlapping features. • The genotype-phenotype correlation of ATP1A3-disorders remains unclear. What is new: • In this study, the genotypes and phenotypes of ATP1A3-related disorders from Southwest of China were described. The splice-site variation c.2542+1G>T was detected for the first time in ATP1A3-related disorders. • The prognosis of twins with AHC p. Gly947Arg was more serious than AHC cases with other variants, which was inconsistent with previous reports. The phenomenon indicated the diversity of the correlation between the genotype and phenotype.

ATP6V0C gene variants were identified in individuals with epilepsy, with or without developmental delay

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

A Heterozygous Pathogenic Variant in the ATP6V1A Gene Triggering Epilepsy in a Large Chinese Pedigree.

ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated with epilepsy

Synonymous variants in the ATP6AP2 gene may lead to developmental and epileptic encephalopathy

Epilepsy due to potential loss of ATP6V1B2 function with mechanistic insight by a Drosophila Vha55 model

Expanding the Spectrum of Autosomal Dominant ATP6V1A-Related Disease: Case Report and Literature Review

ATP1A1 De Novo Mutation-Related Disorders: Clinical and Genetic Features

ZFHX3 variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures

De novo variants in KCNJ3 are associated with early-onset epilepsy

ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA

Recurrent de novo single point variant on the gene encoding Na+/K+ pump results in epilepsy

ATP6V0A1 encoding the a1-subunit of the V0 domain of vacuolar H+-ATPases is essential for brain development in humans and mice

Recessive APC2 Missense Variants Associated with Epilepsies Without Neurodevelopmental Disorders.

Role of TRAK1 variants in epilepsy: genotype–phenotype analysis in a pediatric case of epilepsy with developmental disorder

Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies

Germline De Novo Variants in CSNK2B in Chinese Patients with Epilepsy.

Expansion of the Mutation and Phenotype Spectrum of the GABRA2-related Developmental and Epileptic Encephalopathy78

ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients.

A Heterozygous Missense Variant in the YWHAG Gene Causing Developmental and Epileptic Encephalopathy 56 in a Chinese Family.